The benefit of pancreatic cancer surveillance in carriers of germline BRCA1/2 pathogenic variants.
Laish I, Schechter M, Dancour A, Lieberman S, Levi Z, Goldberg Y, Kedar I, Hasnis E, Half E, Levi GR, Katz L, Vainer ED, Genzel D, Aharoni M, Chen-Shtoyerman R, Abu-Freha N, Raitses-Gurevich M, Golan T, Bernstein-Molho R, Ben Yehoyada M, Gluck N, Rosner G.
Laish I, et al. Among authors: abu freha n.
Cancer. 2024 Jan;130(2):256-266. doi: 10.1002/cncr.35052. Epub 2023 Oct 20.
Cancer. 2024.
PMID: 37861363
Free article.